XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid in Capital [Member]
Accumulated Other Comprehensive Losses [Member]
(Accumulated losses) Retained earnings
Noncontrolling Interest [Member]
Balance, beginning of period at Dec. 31, 2020 $ 806,863,000 $ 1,384,000 $ 0 $ 993,052,000 $ (28,806,000) $ (158,919,000) $ 152,000
Balance, beginning of period, shares at Dec. 31, 2020   138,387,890 1        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (40,972,000) $ 0 $ 0 0 0 (40,970,000) (2,000)
Other comprehensive income (loss) 317,000 0 0 0 317,000 0 0
Total comprehensive income (loss) (40,655,000) 0 0 0 317,000 (40,970,000) (2,000)
Share-based compensation for equity classified awards (538,000) 0 0 (538,000) 0 0 0
Acquisition of noncontrolling interest (853,000) 0 0 (703,000) 0 0 (150,000)
Balance, end of period at Mar. 31, 2021 764,817,000 $ 1,384,000 $ 0 991,811,000 (28,489,000) (199,889,000) 0
Balance, end of period, shares at Mar. 31, 2021   138,387,890 1        
Balance, beginning of period at Dec. 31, 2021 1,077,502,000 $ 1,677,000 $ 0 1,089,547,000 (44,228,000) 30,506,000 0
Balance, beginning of period, shares at Dec. 31, 2021   167,645,373 1        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 269,898,000 $ 0 $ 0 0 0 269,898,000 0
Other comprehensive income (loss) 16,258,000 0 0 0 16,258,000 0 0
Total comprehensive income (loss) 286,156,000 0 0 0 16,258,000 269,898,000 0
Share-based compensation for equity classified awards 84,000 0 0 84,000 0 0 0
Dividends declared (150,881,000) 0 0 0 0 (150,881,000) 0
Balance, end of period at Mar. 31, 2022 $ 1,212,861,000 $ 1,677,000 $ 0 $ 1,089,631,000 $ (27,970,000) $ 149,523,000 $ 0
Balance, end of period, shares at Mar. 31, 2022   167,645,373 1